Nucleic Acid Extraction for PCR and NGS: Methods, Quality Control, and Best Practices

When a real-time PCR run produces unexpectedly high Ct values or an NGS library fails quality control, the problem may start before amplification or sequencing—with nucleic acid extraction.

DNA and RNA extraction is a critical step in molecular workflows. Poor recovery, contamination, or inhibitor carryover can affect downstream results, even when assays and instruments perform as expected.

Understanding extraction methods, sample-specific challenges, and essential quality checks can help laboratories improve consistency and reduce avoidable failures.

Why Nucleic Acid Extraction Quality Matters

Extraction must recover usable DNA or RNA while removing substances that could interfere with downstream applications.

Poor extraction performance can contribute to:

• PCR inhibition: Heme, heparin, residual ethanol, and certain salts may interfere with amplification, delay Ct values, or contribute to false-negative results.
• Low yield: Insufficient nucleic acid recovery can affect low-abundance targets and reduce available material for analysis.
• Degradation: Fragmented DNA or RNA may be unsuitable for applications requiring longer, intact molecules.
• Contamination: Sample-to-sample contamination can produce misleading results.
• Variability: Inconsistent processing can make results difficult to compare across batches.

PCR workflows depend on sufficient amplifiable material with minimal inhibitors. NGS workflows may also require specific input quantities, fragment-size distributions, and nucleic acid integrity.

Magnetic Bead vs. Spin Column Extraction

Magnetic bead and silica spin column technologies are two widely used approaches to nucleic acid purification. Both isolate DNA or RNA through binding, washing, and elution, but they differ in processing requirements and automation capabilities.

Magnetic bead extraction is particularly useful for laboratories seeking automation, reduced manual handling, and consistent processing conditions.

Spin column extraction offers a straightforward purification method for laboratories processing smaller batches or working without dedicated automation equipment.

Neither technology is universally superior. Performance depends on the extraction chemistry, specimen type, processing protocol, and downstream application.

When Does Automated Extraction Make Sense?

Manual extraction may be practical for smaller workloads, while automated systems can help laboratories standardize repetitive steps and reduce hands-on time. Depending on the instrument, automation may also support protocol management and processing documentation.

Jant Pharmacal offers instruments such as the Allsheng Auto-Pure 96 Nucleic Acid Purification System, supporting automated purification across up to 96 samples per run, and the Genolution Nextractor NX-48S, designed for automated magnetic-bead DNA/RNA extraction across up to 48 samples per run. Each system requires compatible reagents and protocols.

Laboratories considering automation should evaluate average sample volume, workflow compatibility, equipment requirements, and total processing costs.

How to Choose the Right Nucleic Acid Extraction Kit

Choosing an extraction kit requires more than selecting magnetic beads or spin columns. Five factors should guide the decision:

1. Sample type: Blood, plasma, swabs, tissue, and FFPE specimens may require different lysis conditions and purification chemistries.
2. Target material: Determine whether the application requires DNA, RNA, or total nucleic acids.
3. Sample input and yield: Low-concentration samples may require extraction methods optimized for efficient recovery.
4. Processing volume: Consider daily throughput, batch size, and available laboratory personnel.
5. Downstream compatibility: Ensure extracted material meets the requirements of PCR, RT-PCR, NGS, or other intended applications.

A suitable method should provide consistent recovery while fitting the laboratory’s equipment, sample volume, and workflow requirements.

Extraction Challenges by Sample Type

Different specimens present different extraction challenges. A method that performs well for one sample type may not be suitable for another.

FFPE Tissue

Formalin-fixed paraffin-embedded (FFPE) tissue often contains fragmented or chemically modified nucleic acids. Successful extraction may require deparaffinization, proteinase K digestion, and reversal of cross-links. For RNA extracted from FFPE tissue, metrics such as DV200 may provide more useful information than traditional RNA Integrity Number (RIN) measurements.

Plasma and Cell-Free DNA

Circulating cell-free DNA (cfDNA) is typically present at low concentrations and consists of relatively short fragments. Sample collection, plasma separation, and minimizing genomic DNA contamination are important considerations. Extraction methods should support efficient recovery of short fragments and meet the requirements of the intended downstream application. Dedicated cfDNA extraction workflows may be appropriate; the Accutest Universal Pathogen kit is not being presented here as a cfDNA-specific product.

Respiratory and Other Pathogen-Containing Specimens

Respiratory specimens can contain variable target concentrations and potential amplification inhibitors. Appropriate lysis, inhibitor removal, and extraction controls help support consistent molecular workflows.

For supported pathogen-containing specimens, the Accutest Universal Pathogen DNA/RNA Extraction and Purification Kit provides magnetic-bead purification suitable for PCR, qRT-PCR, and other compatible molecular research applications.

Read more about multiplex RT-PCR workflows for respiratory season.

Blood and Other Biological Fluids

Blood specimens may contain PCR inhibitors such as hemoglobin and certain anticoagulants, particularly heparin. Selecting appropriate collection materials and extraction protocols can help minimize inhibitor carryover.

Essential Quality Control for Nucleic Acid Extraction

Nucleic acid yield alone does not determine whether a sample is suitable for PCR or NGS. Laboratories should consider several complementary quality checks.

1. Yield and concentration: Fluorometric assays provide selective nucleic acid quantification and are often preferred for low-concentration samples and NGS input assessment.
2. Purity: UV absorbance ratios can help identify potential contamination. Common A260/280 reference values are approximately 1.8 for DNA and 2.0 for RNA; A260/230 offers additional context. Acceptable ratios do not guarantee the absence of PCR inhibitors.
3. Integrity and fragment size: Gel electrophoresis or fragment analysis can help assess degradation and fragment-size distribution, particularly for NGS applications.
4. Extraction controls: Appropriate positive controls can help monitor recovery, while negative extraction controls can identify contamination. An internal control added before extraction and monitored appropriately may help reveal extraction failure or downstream inhibition.

Quality control requirements should reflect the specimen, assay, and laboratory workflow.

Common Extraction Mistakes to Avoid

• Incomplete lysis: Insufficient sample disruption can reduce nucleic acid recovery.
• Residual ethanol or wash buffer: Carryover may interfere with downstream enzymatic reactions.
• Sample overloading: Exceeding recommended input amounts can compromise purification performance.
• Improper storage: Inappropriate handling or repeated freeze-thaw cycles may degrade nucleic acids.
• Inadequate controls: Missing extraction controls can make contamination or processing failures difficult to identify.

Following manufacturer instructions and appropriate laboratory procedures can help reduce these risks.

Matching Extraction Methods to PCR and NGS

Extraction should be selected with the downstream application in mind. For real-time PCR, consistent target recovery and effective inhibitor removal are important for reliable amplification. For NGS, additional considerations may include input concentration, total nucleic acid quantity, fragment size, and integrity.

Not all NGS workflows require intact, high-molecular-weight nucleic acids. For example, FFPE and cfDNA applications often use fragmented starting material. The most appropriate extraction method produces material compatible with the intended assay or library preparation workflow.

See our guides to NGS vs. Real-Time PCR and real-time PCR troubleshooting.

Frequently Asked Questions

Conclusion

Nucleic acid extraction is a foundational step in PCR and NGS workflows. Choosing the appropriate purification method, accounting for specimen-specific challenges, and incorporating quality control measures can help laboratories improve consistency and minimize downstream problems.

Jant Pharmacal offers extraction reagents and automated purification systems to support a range of molecular research applications.

Product intended uses and regulatory classifications vary. Research Use Only (RUO) products are not intended for use in diagnostic procedures. Refer to individual product documentation and applicable regulatory requirements before use.

References

1. Schrader C, Schielke A, Ellerbroek L, Johne R. PCR inhibitors – occurrence, properties and removal. Journal of Applied Microbiology. 2012;113(5):1014–1026.
2. Bustin SA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry. 2009;55(4):611–622.